Eversept Partners, LP - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 139 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eversept Partners, LP ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,665,340
-9.3%
122,643
+117.3%
0.40%
-8.1%
Q2 2023$5,142,504
-35.8%
56,449
-63.5%
0.43%
-38.7%
Q4 2022$8,004,501
+92.1%
154,796
+22.5%
0.70%
+142.6%
Q3 2021$4,166,144
+652.6%
126,400
+879.8%
0.29%
+588.1%
Q1 2021$553,539
+153.6%
12,900
+238.1%
0.04%
+61.5%
Q4 2020$218,275
-91.1%
3,816
-95.3%
0.03%
-95.2%
Q3 2020$2,451,825
-82.2%
81,267
-80.7%
0.54%
-71.1%
Q2 2020$13,747,639
-42.9%
420,932
-53.2%
1.88%
-68.5%
Q1 2020$24,096,908
+153.5%
899,474
+189.8%
5.99%
+257.0%
Q4 2019$9,504,724
+396.2%
310,409
+290.4%
1.68%
+182.5%
Q3 2019$1,915,372
-35.6%
79,509
-32.2%
0.59%
-28.6%
Q2 2019$2,972,610
+46.1%
117,309
+12.4%
0.83%
+40.1%
Q1 2019$2,034,806
+44.3%
104,349
-2.4%
0.59%
-22.1%
Q4 2018$1,409,747
-20.9%
106,880
+6.6%
0.76%
-2.6%
Q3 2018$1,783,245
-17.6%
100,295
+1.9%
0.78%
-20.9%
Q2 2018$2,164,69098,3950.99%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders